Biopharma Cold Chain Sourcebook
The 2020 Biopharma Cold Chain Sourcebook is an invaluable resource. Based on detailed analysis of rapidly changing regulatory practices around the world and the growth of clinical and commercial shipping volumes worldwide.
Are you an industry supply chain/logistics manager who needs to organize and streamline your shipping processes for temperature-controlled samples and products, in the US and around the world? Are you a business development executive in the life sciences services industry looking to improve your company’s position in offering temperature-controlled technology and services to biopharma? For both of you—and many others—the 2020 Biopharma Cold Chain Sourcebook will be an invaluable resource. Based on detailed analysis of rapidly changing regulatory practices around the world, and the growth of clinical and commercial shipping volumes worldwide, the temperature-controlled delivery market is one of the most dynamic fields in life sciences today. Click on “Introduction” below to get our overview of the 2020 edition of the Sourcebook, and click on “Table of Contents” to review the chapter-by-chapter details of this 205-page report.
Sourcebook IntroSourcebook Table of Contents
Order now: The 2020 Biopharma Cold Chain Sourcebook can be delivered as hardcopy or a PDF. Call (917) 648-3919, or e-mail [email protected] for more details.
How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease
July 7th 2025A qualitative study explores how MA plan leaders, kidney care managers, and dialysis providers perceive the benefits, risks, and marketing practices surrounding MA enrollment for patients with end-stage kidney disease.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.
